Restless Leg Syndrome Forecast in 13 Major Markets 2016-2026 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/jsskg4/restless_leg) has announced the addition of the "Restless Leg Syndrome Forecast in 13 Major Markets 2016-2026" report to their offering.

Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disorder, is a sensimotor sleep disorder. Clinically, RLS is characterized by disagreeable leg sensations occurring most often at sleep onset that provoke an irresistible urge to move legs. Patients with RLS typically complain of itching, creeping and tingling in their legs, usually between the ankle and the knee. The unpleasant sensations occur when the individual is at rest and are more pronounced in the evening or at night. The unpleasant sensations are relieved temporarily with leg movements.

This report provides the current prevalent population for Restless Legs Syndrome across 13 Major Markets (USA, France, Germany, Italy, Spain, UK, Turkey, Brazil, Mexico, Republic of Korea, India, China and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

This report has quantified several of the main symptoms and co-morbidities of Restless Legs Syndrome and presented them alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Key Topics Covered:

1. List of tables and figures

2. Introduction

3. Cause of the disease

4. Risk factors & prevention

5. Diagnosis of the disease

6. Variation by geography/ethnicity

7. Disease prognosis & clinical course

8. Key comorbid conditions / features associated with the disease

9. Methodology for quantification of patient numbers

10. Top-line prevalence for restless legs syndrome

11. Features of restless legs syndrome

12. Conditions associated with restless legs syndrome

13. Abbreviations used in the report

14. Patient-based offering

15. Online pricing data & platforms

16. References

17. Appendix

For more information visit http://www.researchandmarkets.com/research/jsskg4/restless_leg

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals